Table 1.
Baseline | All | Vaccinated | Not vaccinated | P |
---|---|---|---|---|
n (%) | 132 (100) | 101 (77) | 31 (23) | — |
Age, yr | 67.54 ± 15.71 | 68.89 ± 14.86 | 63.13 ± 17.74 | 0.0739 |
Male, n (%) | 75 (57) | 60 (59) | 15 (48) | 0.3054 |
Dialysis vintage, yr | 2.21 [0.80–4.68] | 2.28 [0.81–4.58] | 2.21 [0.41–5.97] | 0.5637 |
Charlson Comorbidity Index | 8 [5–10] | 8 [5–10] | 8 [6–9] | 0.3649 |
T1 | Responders | Nonresponders | P |
---|---|---|---|
No. | 35 | 60 | — |
Age, yr | 62.31 ± 16.20 | 73.72 ± 11.18 | 0.0001 |
Male, n (%) | 20 (57) | 35 (58) | 0.9999 |
Dialysis vintage, yr | 1.44 [0.67–3.97] | 2.99 [0.96–5.99] | 0.3149 |
Charlson Comorbidity Index | 6 [4–8] | 9 [7–10] | 0.0006 |
Anti–SARS-CoV-2 S IgG titer, U/ml | 8.22 [1.73–28.70] | — | — |
S, spike; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; T1, time of the second vaccine injection.
Age is expressed as mean ± SD; dialysis vintage and Charlson Comorbidity Index are expressed as median [interquartile range].
Bold P values indicate statistically significant variables.